These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 15694713)

  • 1. Why major nonenzymatic glycation sites of human serum albumin are preferred to other residues?
    Marashi SA; Safarian S; Moosavi-Movahedi AA
    Med Hypotheses; 2005; 64(4):881. PubMed ID: 15694713
    [No Abstract]   [Full Text] [Related]  

  • 2. Glycation of interferon-beta-1b and human serum albumin in a lyophilized glucose formulation. Part III: application of proteomic analysis to the manufacture of biological drugs.
    Zheng X; Wu SL; Hancock WS
    Int J Pharm; 2006 Sep; 322(1-2):136-45. PubMed ID: 16920285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of human serum albumin and its clinically relevant modification with oligoribonucleotides.
    Gerasimova YV; Erchenko IA; Shakirov MM; Godovikova TS
    Bioorg Med Chem Lett; 2008 Aug; 18(16):4511-4. PubMed ID: 18674900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Location of high and low affinity fatty acid binding sites on human serum albumin revealed by NMR drug-competition analysis.
    Simard JR; Zunszain PA; Hamilton JA; Curry S
    J Mol Biol; 2006 Aug; 361(2):336-51. PubMed ID: 16844140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determining molecular binding sites on human serum albumin by displacement of oleic acid.
    Sarver RW; Gao H; Tian F
    Anal Biochem; 2005 Dec; 347(2):297-302. PubMed ID: 16289007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temperature-dependent simultaneous ligand binding in human serum albumin.
    Sinha SS; Mitra RK; Pal SK
    J Phys Chem B; 2008 Apr; 112(16):4884-91. PubMed ID: 18386863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural basis of the drug-binding specificity of human serum albumin.
    Ghuman J; Zunszain PA; Petitpas I; Bhattacharya AA; Otagiri M; Curry S
    J Mol Biol; 2005 Oct; 353(1):38-52. PubMed ID: 16169013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subdomain IIIA of dog albumin contains a binding site similar to site II of human albumin.
    Kaneko K; Fukuda H; Chuang VT; Yamasaki K; Kawahara K; Nakayama H; Suenaga A; Maruyama T; Otagiri M
    Drug Metab Dispos; 2008 Jan; 36(1):81-6. PubMed ID: 17925384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The extraordinary ligand binding properties of human serum albumin.
    Fasano M; Curry S; Terreno E; Galliano M; Fanali G; Narciso P; Notari S; Ascenzi P
    IUBMB Life; 2005 Dec; 57(12):787-96. PubMed ID: 16393781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chain length-dependent binding of fatty acid anions to human serum albumin studied by site-directed mutagenesis.
    Kragh-Hansen U; Watanabe H; Nakajou K; Iwao Y; Otagiri M
    J Mol Biol; 2006 Oct; 363(3):702-12. PubMed ID: 16979183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A fluorescence study of human serum albumin binding sites modification by hypochlorite.
    Lissi E; Alicia Biasutti M; Abuin E; León L
    J Photochem Photobiol B; 2009 Feb; 94(2):77-81. PubMed ID: 19036598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes of serum albumin affinity for aspirin induced by fatty acid.
    Bojko B; Sułkowska A; Maciazek M; Równicka J; Njau F; Sułkowski WW
    Int J Biol Macromol; 2008 May; 42(4):314-23. PubMed ID: 18346781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory effect of vitamin B6 on nonenzymatic glycation of albumin and hemoglobin.
    Michailova M; Keita Y; Caspary S; Solem E; Kratzer W; Wörner G; Rietbrock N
    Int J Clin Pharmacol Ther Toxicol; 1992 Nov; 30(11):547-8. PubMed ID: 1490829
    [No Abstract]   [Full Text] [Related]  

  • 14. Stereospecific recognition of a spirosuccinimide type aldose reductase inhibitor (AS-3201) by plasma proteins: a significant role of specific binding by serum albumin in the improved potency and stability.
    Kurono M; Fujii A; Murata M; Fujitani B; Negoro T
    Biochem Pharmacol; 2006 Jan; 71(3):338-53. PubMed ID: 16324683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptide mapping of human serum albumin modified minimally by methylglyoxal in vitro and in vivo.
    Ahmed N; Thornalley PJ
    Ann N Y Acad Sci; 2005 Jun; 1043():260-6. PubMed ID: 16037246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Human serum albumin: news about an old acquaintance].
    Kragh-Hansen U
    Ugeskr Laeger; 2007 Oct; 169(41):3467-70. PubMed ID: 17967273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding of warfarin influences the acid-base equilibrium of H242 in sudlow site I of human serum albumin.
    Perry JL; Goldsmith MR; Williams TR; Radack KP; Christensen T; Gorham J; Pasquinelli MA; Toone EJ; Beratan DN; Simon JD
    Photochem Photobiol; 2006; 82(5):1365-9. PubMed ID: 16563025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Engineering of a femtomolar affinity binding protein to human serum albumin.
    Jonsson A; Dogan J; Herne N; Abrahmsén L; Nygren PA
    Protein Eng Des Sel; 2008 Aug; 21(8):515-27. PubMed ID: 18499681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of endogenous ligands on the biological role of human serum albumin in S-nitrosylation.
    Ishima Y; Akaike T; Kragh-Hansen U; Hiroyama S; Sawa T; Maruyama T; Kai T; Otagiri M
    Biochem Biophys Res Commun; 2007 Dec; 364(4):790-5. PubMed ID: 18273439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of flavones on glucose-induced changes in human serum albumen.
    Coussons PJ; Jacoby J; Skamarauskas JT; Hunt JV
    Biochem Soc Trans; 1996 Aug; 24(3):397S. PubMed ID: 8878941
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.